Literature DB >> 9322325

Conservative treatment of acute and chronic nonspecific low back pain. A systematic review of randomized controlled trials of the most common interventions.

M W van Tulder1, B W Koes, L M Bouter.   

Abstract

STUDY
DESIGN: A systematic review of randomized controlled trials.
OBJECTIVES: To assess the effectiveness of the most common conservative types of treatment for patients with acute and chronic nonspecific low back pain. SUMMARY OF BACKGROUND DATA: Many treatment options for acute and chronic low back pain are available, but little is known about the optimal treatment strategy.
METHODS: A rating system was used to assess the strength of the evidence, based on the methodologic quality of the randomized controlled trials, the relevance of the outcome measures, and the consistency of the results.
RESULTS: The number of randomized controlled trials identified varied widely with regard to the interventions involved. The scores ranged from 20 to 79 points for acute low back pain and from 19 to 79 points for chronic low back pain on a 100-point scale, indicating the overall poor quality of the trials. Overall, only 28 (35%) randomized controlled trials on acute low back pain and 20 (25%) on chronic low back pain had a methodologic score of 50 or more points, and were considered to be of high quality. Various methodologic flaws were identified. Strong evidence was found for the effectiveness of muscle relaxants and nonsteroidal anti-inflammatory drugs and the ineffectiveness of exercise therapy for acute low back pain; strong evidence also was found for the effectiveness of manipulation, back schools, and exercise therapy for chronic low back pain, especially for short-term effects.
CONCLUSIONS: The quality of the design, execution, and reporting of randomized controlled trials should be improved, to establish strong evidence for the effectiveness of the various therapeutic interventions for acute and chronic low back pain.

Entities:  

Mesh:

Year:  1997        PMID: 9322325     DOI: 10.1097/00007632-199709150-00012

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.468


  123 in total

Review 1.  The stigmatisation and denial of mental illness in athletes.

Authors:  T L Schwenk
Journal:  Br J Sports Med       Date:  2000-02       Impact factor: 13.800

Review 2.  Exercise and the prevention of back pain disability.

Authors:  M R Underwood
Journal:  Br J Sports Med       Date:  2000-02       Impact factor: 13.800

Review 3.  Effective physiotherapy.

Authors:  R D Herbert; C G Maher; A M Moseley; C Sherrington
Journal:  BMJ       Date:  2001-10-06

Review 4.  Failed back surgery syndrome.

Authors:  V C Anderson; Z Israel
Journal:  Curr Rev Pain       Date:  2000

Review 5.  Chiropractic in the United States: trends and issues.

Authors:  Richard A Cooper; Heather J McKee
Journal:  Milbank Q       Date:  2003       Impact factor: 4.911

6.  Chiropractic care: a flawed risk-benefit analysis?

Authors:  Eric L Hurwitz; William C Meeker; Monica Smith
Journal:  Am J Public Health       Date:  2003-04       Impact factor: 9.308

Review 7.  [Drug therapy of back pain].

Authors:  M A Rauschmann; D von Stechow
Journal:  Orthopade       Date:  2003-12       Impact factor: 1.087

8.  Intramuscular Temperature Rises With Topical Analgesics Used as Coupling Agents During Therapeutic Ultrasound.

Authors:  J William Myrer; Gary J. Measom; Gilbert W. Fellingham
Journal:  J Athl Train       Date:  2001-03       Impact factor: 2.860

9.  Joint manipulation reduces hyperalgesia by activation of monoamine receptors but not opioid or GABA receptors in the spinal cord.

Authors:  D A Skyba; R Radhakrishnan; J J Rohlwing; A Wright; K A Sluka
Journal:  Pain       Date:  2003-11       Impact factor: 6.961

10.  Balneotherapy for chronic low back pain: a randomized, controlled study.

Authors:  Nur Kesiktas; Sinem Karakas; Kerem Gun; Nuran Gun; Sadiye Murat; Murat Uludag
Journal:  Rheumatol Int       Date:  2011-09-30       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.